Sen. John Hoeven sold Pfizer (PFE)

Sen. John Hoeven (R-ND) · $50K–$100K · traded Jan 20, 2017

Transaction: Sold (full)
Amount: $50K–$100K
Owner: The member
Traded: Jan 20, 2017
Disclosed: Jan 25, 2017
Days to disclose: 5
Asset type: Stock
As filed: Pfizer Inc.
Industry: Drug Manufacturers - General · Healthcare

Official filing ↗All of Hoeven's trades All Congress trades in PFE

Other trades in this filing

DisclosedTradeAmount

Jan 25, 2017
Sold (full) Merck & Co. MRK
$50K–$100K · Traded Jan 25, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Willis Towers Watson Public Limited Company WTW
$50K–$100K · Traded Jan 24, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought V.F. VFC
$50K–$100K · Traded Jan 23, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Cisco Systems CSCO
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought Verizon Communications VZ
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Sold (full) Johnson & Johnson JNJ
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought Intel INTC
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought The Procter & Gamble Company PG
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought The Coca-Cola Company KO
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Bristol-Myers Squibb Company BMY
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought PepsiCo PEP
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Amgen AMGN
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Sold (full) AbbVie ABBV
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought AT&T T
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Sold (full) THE CAMPBELL FUND TRUST - SERIES A Company: THE CAMPBELL FUND TRUST - SERIES A (BALTIMORE, MARYLAND) Description: INVETMENT MANAGEMENT IN FUTURES AND CASH EQUITY STRATEGIES
$50K–$100K · Traded Jan 12, 2017 · disclosed Jan 25, 2017
$50K–$100K

Recent Congress trades in PFE

DisclosedTradeAmount

Oct 9, 2026
Rep. Ro Khanna (D-CA-17)
Bought Pfizer PFE
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 9, 2026 · Spouse
$1K–$15K
Oct 9, 2026
Rep. Ro Khanna (D-CA-17)
Bought Pfizer PFE
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 9, 2026 · Dependent
$1K–$15K
Oct 9, 2026
Rep. Ro Khanna (D-CA-17)
Sold Pfizer PFE
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 9, 2026 · Spouse
$15K–$50K
Aug 14, 2026
Rep. Carol D. Miller (R-WV-1)
Sold (full) Pfizer PFE
$15K–$50K · Traded Mar 10, 2025 · disclosed Aug 14, 2026 · Spouse · filed 522 days later
$15K–$50K
Aug 12, 2026
Rep. Ro Khanna (D-CA-17)
Bought Pfizer PFE
$1K–$15K · Traded Jul 7, 2026 · disclosed Aug 12, 2026 · Dependent
$1K–$15K
Aug 10, 2026
Rep. Michael A. Rulli (R-OH-6)
Sold Pfizer PFE
$1K–$15K · Traded Nov 26, 2024 · disclosed Aug 10, 2026 · filed 622 days later
$1K–$15K
Jul 21, 2026
Sen. Alan Armstrong (R-OK)
Sold (full) Pfizer PFE
$50K–$100K · Traded Mar 24, 2026 · disclosed Jul 21, 2026 · filed 119 days later
Committee overlap: HELP
$50K–$100K
Jul 16, 2026
Sen. Tommy Tuberville (R-AL)
Sold Pfizer PFE
$15K–$50K · Traded Jun 8, 2026 · disclosed Jul 16, 2026 · Joint
Committee overlap: HELP
$15K–$50K

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.